Accordingly, p - ERK upregulation was observed not only
in tumor samples of PTCL - NOS patients with KMT2D mutations, but also in those of xenografted T - lymphoma mice bearing KMT2D V5486M mutants, the latter being inhibited by combined treatment with chidamide and decitabine (Figure 5F, G).
(D) Immunostaining of H3K4me3 and H3K18ac
in tumor samples of PTCL - NOS patients with or without KMT2D or EP300 mutations.
(G) Immunostaining of p - ERK
in tumor samples of xenografted murine models bearing KMT2D V5486 mutants treated with CHID and / or DECI.
(F) Immunohistochemical assay of p - ERK
in tumor samples of PTCL - NOS patients with or without KMT2D mutations.
Not exact matches
Interest
in liquid biopsy has escalated
in recent years due to the minimally invasive
sampling method, potential to overcome the challenges
of tumor heterogeneity, and the potential for longitudinal monitoring
of tumor burden through serial
sampling.
To determine how the cells switch from one type to another, they took three human uterine carcinosarcoma
samples and sequenced the genomes
of cells
in two parts
of each
tumor: the carcinoma and sarcoma components.
The focus
of those hopes is the liquid biopsy: a test that could detect and analyze a solid
tumor from biomarkers
in the bloodstream or other easily
sampled body fluids, such as saliva.
While the latter has a reputation for being hard to isolate, she explains that even degraded RNA generally contains enough intact sequence to analyze — provided investigators can detect the scarce
tumor signals against the immense background
of other RNA molecules
in a
sample.
«Circulating
tumor cells have the advantage that they are... intact living cells,» says Michael Kazinski, senior director and head
of global product management for
sample technologies at Qiagen
in Hilden, Germany.
Analyzing a database
of nearly 800 multiple myeloma patient
samples, they discovered that 162 patients with low ADAR1 levels
in their
tumor cells survived significantly longer over a three - year period compared to 159 patients with high ADAR1 levels.
Ependymomas also occur
in adults, but
in the study, none
of the adult
tumor samples had reduced H3K27me3.
The study's 31
samples of dog
tumors was compared to 40 normal canine tissues
samples as a way
of estimating the variance
in gene expression.
Researchers used tissue and blood
samples to show that the gammopathy (a precursor to myeloma)
in both mice and patients with Gaucher disease is triggered by specific lipids, and that the antibodies made by
tumor cells
in nearly a third
of myeloma patients are directed against such lipids.
HBI member V. Wee Yong, PhD and research associate Susobhan Sarkar, PhD, and their team including researchers from the Department
of Clinical Neurosciences and the university's Southern Alberta Cancer Research Institute, looked at human brain
tumor samples and discovered that specialized immune cells
in brain
tumor patients are compromised.
In blood
samples from 1005 patients with eight types
of tumors that had evidently not yet metastasized, the test detected between 33 % and 98 %
of cases, depending on the
tumor type (see graph, above).
After surgical removal, the metabolic processes
in a
tumor change
in a very short period
of time, so that valuable information about the
tumor tissue is lost during a conventional
sampling procedure.
However, many studies have found the inconsistency
of EGFR mutation status
in plasma DNA
samples as compared to
tumor tissue DNA
samples.
She has sequenced hundreds
of tumor samples from across the island
in an effort to understand how it evolves and how that affects the devils» survival rates.
To that end,
in collaboration with the University
of Zurich and MD Anderson Cancer Center, the researchers tested melanoma
tumor samples from human patients undergoing treatment with the same targeted therapies.
The finding, reported by a Stand Up to Cancer - Prostate Cancer Foundation Dream Team
in the May 21 edition
of the journal Cell, is based on an analysis
of tumor samples from 150 men with metastatic prostate cancer that no longer responded to standard hormone - blocking therapy.
Spearheaded by first author Christopher McNair, PhD, a graduate student
in the laboratory
of Dr. Knudsen, the study undertook an extensive analysis
of tumor samples and cell - free DNA
samples from patients with advanced, lethal - stage prostate cancer.
A global analysis
of metabolites and small molecules
in urine
samples from patients with adrenal cancer has identified four biochemicals that, when measured together, can distinguish malignant from benign adrenal
tumors, according to study results presented at the 2015 Annual Clinical Congress
of the American College
of Surgeons.
Analysis
of blood and tissue
samples from one patient revealed that plakoglobin was expressed
in CTC clusters but not single CTCs and also was expressed
in some portions
of both the primary
tumor and metastases.
The researchers analyzed the
samples using immunohistochemistry and RNA sequencing to study the changes
in the
tumor immune microenvironment
of patients who received and did not receive chemotherapy, and changes before and after chemotherapy.
The latter, presented by Eric Lander
of the Broad Institute
in Cambridge, Massachusetts, would systematically sequence
tumor samples for mutations involved
in cancer to speed up the search for new drugs and diagnostics.
From tissue and cell
samples from five glioblastoma patients, the scientists obtained 33 individual cancer cells capable
of reproduction, which grew into very different
tumors in the lab.
A total
of 67 biochemical features discriminated cancer from benign
tumors in these
samples, but only four specific metabolites could be considered as biomarkers for cancer: creatinine riboside, tryptophan, Nε, Nε, Nε - trimethyllysine, and 3 - methylhistidine.
A new investigation
of more than 48,000 stored
tumor samples finds evidence
of a key deficiency
in a repair mechanism designed to keep DNA from being mutated and causing cancer.
To see whether Lin28 might be a factor
in Wilms
tumor development, Daley and an international team
of collaborators measured the gene's expression
in tumor samples from 105 Wilms patients.
Caris performed the molecular profiling on 48,733 solid
tumor samples to assess the prevalence
of homologous recombination deficiency
in about 20 different types
of solid
tumors.
To better understand the formation
of metastases
in pancreatic cancer, Christine Iacobuzio - Donahue, M.D., Ph.D., professor
of pathology at Memorial Sloan Kettering Cancer Center, collected
tumor samples from eight patients with the most common form
of pancreatic cancer (pancreatic ductal adenocarcinoma) immediately after their deaths.
The researchers next will turn to analyzing the presence
of myoferlin
in samples from numerous human
tumor types available
in an Ohio State tissue bank, which will allow them to compare protein levels
in tumors to clinical outcomes for the patients who provided the
samples.
The Ogretmen laboratory screened previously reported microarray data sets
of several human
tumor tissues (metastatic head and neck squamous cell carcinoma, melanoma, and renal cell carcinoma) and showed that,
in these
samples, only the levels
of CerS4 were significantly decreased.
They found that the levels
of two specific tRNAs were significantly higher
in metastatic cells and metastatic
tumors than
in primary
tumors that did not metastasize or healthy
samples.
Unlike other solid
tumors, there has been limited progress
in understanding the contribution
of genetic risk factors to the development
of uveal melanoma, researchers say, primarily due to the absence
of comprehensive genetic data from patients as the large
sample cohorts for this rare cancer type have not been available for research.
«The enhancing effect was not seen
in a patient
tumor sample with a low level
of NRP - 1 expression on the vasculature.
«
In the tumor sample from a patient with high NRP - 1 expression, there was a significant improvement in the efficacy of the nanoparticle to induce tumor shrinkage,» said Ne
In the
tumor sample from a patient with high NRP - 1 expression, there was a significant improvement
in the efficacy of the nanoparticle to induce tumor shrinkage,» said Ne
in the efficacy
of the nanoparticle to induce
tumor shrinkage,» said Nel.
Capture experiments were also performed on whole blood
samples, and the capture efficiency was
in a high range
of 81 - 95 %, at different
tumor cell concentrations.
To make the vaccine, researchers took a
sample of a patient's
tumors, which
in this trial were made up
of B cells (white blood cells that help the body battle disease and infection).
The role
of rebiopsy and repeat analysis
in the setting
of post-treatment relapse, along with testing
of blood
samples for mutations
in circulating
tumor cells, cell free
tumor DNA, or exosomes will be considered.
They then conducted biochemical analyses to identify neuroligin - 3, confirm that the protein could stimulate
tumor growth
in cultured
samples of several kinds
of human high - grade gliomas and study which signals the protein uses within glioma cells to promote their growth.
However, an analysis
of the
samples showed a wide variation
of EGFRvIII expression
in patients and over time and
in different areas
of their
tumors.
Cells were extracted from the biopsy
of her
tumor sample for use
in research without her knowledge or consent.
«And we found all three types
of «gain -
of - function» mutations
in the estrogen receptor gene ESR1
in the
tumor samples.»
The researchers were able to replicate this finding by comparing the healthy thyroid tissues
in GTEx to 500
samples taken from thyroid
tumors, compiled by The Cancer Genome Atlas, and giving support to the extensive impact
of FOXE1 on cellular state.
The total environmental DNA
of grape crown gall
tumor disease is revealed
in the genetic profile based on 52 tissue
samples of crown gall
tumor taken from 16 grapevine species.
Working
in mouse models
of breast cancer and breast
tumor samples from patients, Longmore and his colleagues showed that a protein that sits on the surface
of tumor cells, called DDR2, binds to collagen and activates a multistep pathway that encourages
tumor cells to spread.
An additional set
of 18 prostate cancer tissue
samples was analyzed by qPCR and five lncRNAs were found to be significantly higher
in prostate
tumor tissues compared with matched normal tissues.
To search for other characteristics
of ccRCC
tumors that influences immunotherapy response or resistance, the researchers used whole - exome DNA sequencing to analyze
tumor samples from 35 patients treated
in a clinical trial with the checkpoint blocker nivolumab (Opdivo).
Researchers also can't draw inferences from a single
sample on the frequency
of tumors in the Neandertal population, he says.